Summary
This prediction ended on 24.10.22 with a price of €0.64. The BUY prediction by BiotechBee for Tricida performed very badly with a performance of -93.82%. BiotechBee has 40% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Tricida | - | - | - | - |
| iShares Core DAX® | 1,43 % | 2,63 % | 12,46 % | 60,35 % |
| iShares Nasdaq 100 | 1,89 % | -0,46 % | 1,25 % | 85,81 % |
| iShares Nikkei 225® | -1,62 % | 11,10 % | 27,38 % | 64,40 % |
| iShares S&P 500 | 1,92 % | 1,16 % | 1,63 % | 59,42 % |
According to BiotechBee what are the pros and cons of Tricida for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Tricida diskutieren
Buy mit Kursziel 25,0